Genexine "Indonesian FDA Approves Phase 2/3 Clinical Trials of COVID-19 Vaccine"

[Asia Economy Reporter Ji Yeon-jin] Genexine announced on the 7th that the Indonesian Food and Drug Authority has approved the phase 2/3 clinical trial plan for the COVID-19 preventive DNA vaccine (GX-19N).